Clinical Trial Update: Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the acute effect of combining teriparatide with either a bisphosphonate or denosumab on bone resorption in postmenopausal osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Bisphosphonate
• Denosumab (denosumab)
• Teriparatide (Teriparatide)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Postmenopausal Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2016-12-01